Study Protocols Should Check For Alternative Medicine Use - CDER Seminar
This article was originally published in The Tan Sheet
Executive Summary
Clinical trial entry protocols should include specific questions about complementary and alternative medicine use by patients, Seattle-based Northwest Natural Health-Specialty Care Clinic practitioner Dan Labriola told an FDA Center for Drug Evaluation & Research seminar Feb. 21.